PYLCLARI® should be used in designated nuclear medicine facilities only and should only be handled by authorised personnel.

This medicinal product is for diagnostic use only

PYLCLARITM is indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions with positron emission tomography (PET) in adults with prostate cancer (PCa) in the following clinical settings:

This medicinal product is for diagnostic use only

PYLCLARI® is indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions with positron emission tomography (PET) in adults with prostate cancer (PCa) in the following clinical settings:

Detailed recommendations for the use of this product can be found in the Summary of Product Characteristics (SmPC)

Looking for training on how to interpret piflufolastat (18F) images?

Refresh your knowledge on guidelines and test yourself with some clinical cases interpretations

Pre-register to our piflufolastat (18F) Image Interpretation Training now

    Privacy Notice:
    Curium and its affiliates (hereinafter “we”), shall be responsible for collecting and processing your personal data (i.e., first name, surname, professional details and email) as data controller, solely for the purposes of managing your registration and participation in the PYLCLARI reader training, as well as offering any required technical support prior, during and after the training, in compliance with applicable data protection laws.
    To facilitate the provision of the training, we have engaged an EU-based third-party service provider and their training platform: Doxaca.
    Following the training, we may contact you and kindly ask you to participate in a post-training survey (a post-market efficacy study) on the training material which was explicitly requested by the competent regulatory authorities. Please note that the survey is completely optional, and you may refuse to participate.
    If you wish to exercise your privacy rights or submit any privacy related query, you can contact Curium’s designated Data Protection Officer (DPO) via email at privacy.office@curiumpharma.com. For more information on Curium’s privacy practices, please read our Privacy Policy.

    Looking for training on how to interpret piflufolastat (18F) images?

    Refresh your knowledge on guidelines and test yourself with some clinical cases interpretations

    [situaciones_clinicas]

    Podcast de expertos

    [podcast_carrusel]
    [podcast_movil]

    El Chester de SEMES en VIH

    [chester_destacado]
    [el_chester_de_semes]

    Contact

    Error: Formulario de contacto no encontrado.

    Pre-register to our piflufolastat (18F) Image Interpretation Training now

    Important notice

    The information on this page is intended for use by healthcare providers only. By continuing, you automatically confirm that you are a professional healthcare provider in a European country

    Yes
    No

    Thank you!

    You are now pre-registered for PYLCLARI™ training. We have received your details and are currently processing your request. Once this is completed, Curium will contact you with instructions on how to access the content.